Selected research
Market Analysis & Forecast
Global At-Home Health Testing Solutions Market Analysis and Forecast 2026-2032
Market perspective
The global At-Home Health Testing Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for At-Home Health Testing Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for At-Home Health Testing Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for At-Home Health Testing Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for At-Home Health Testing Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of At-Home Health Testing Solutions include New Horizon Health Limited, Test Onelife, Creative Biosciences (Guangzhou), AnDall, Everlywell, Modern Fertility, 23andMe, Cue Health and LetsGetChecked, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for At-Home Health Testing Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of At-Home Health Testing Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for At-Home Health Testing Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the At-Home Health Testing Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global At-Home Health Testing Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for At-Home Health Testing Solutions revenue, projected growth trends, production technology, application and end-user industry.
At-Home Health Testing Solutions Segment by Company
New Horizon Health Limited
Test Onelife
Creative Biosciences (Guangzhou)
AnDall
Everlywell
Modern Fertility
23andMe
Cue Health
LetsGetChecked
ixlayer
Pixel by LabCorp
Thriva
MyLab Box
Ash
Viome
SiPhox Health
TytoCare
Randox Health
Nurx
At-Home Health Testing Solutions Segment by Type
Blood Testing
Urine Testing
Others
At-Home Health Testing Solutions Segment by Application
Consumer-Grade Diagnostics
Clinical Grade Diagnosis
At-Home Health Testing Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global At-Home Health Testing Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of At-Home Health Testing Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of At-Home Health Testing Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of At-Home Health Testing Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of At-Home Health Testing Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, At-Home Health Testing Solutions revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Testing
- Urine Testing
- Others
Applications
- Consumer-Grade Diagnostics
- Clinical Grade Diagnosis
Companies covered
- New Horizon Health Limited
- Test Onelife
- Creative Biosciences (Guangzhou)
- AnDall
- Everlywell
- Modern Fertility
- 23andMe
- Cue Health
- LetsGetChecked
- ixlayer
- Pixel by LabCorp
- Thriva
- MyLab Box
- Ash
- Viome
- SiPhox Health
- TytoCare
- Randox Health
- Nurx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 At-Home Health Testing Solutions Market by Type
- 1.2.1 Global At-Home Health Testing Solutions Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Blood Testing
- 1.2.3 Urine Testing
- 1.2.4 Others
- 1.3 At-Home Health Testing Solutions Market by Application
- 1.3.1 Global At-Home Health Testing Solutions Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Consumer-Grade Diagnostics
- 1.3.3 Clinical Grade Diagnosis
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 At-Home Health Testing Solutions Market Dynamics
- 2.1 At-Home Health Testing Solutions Industry Trends
- 2.2 At-Home Health Testing Solutions Industry Drivers
- 2.3 At-Home Health Testing Solutions Industry Opportunities and Challenges
- 2.4 At-Home Health Testing Solutions Industry Restraints
3 Global Growth Perspective
- 3.1 Global At-Home Health Testing Solutions Market Perspective (2021-2032)
- 3.2 Global At-Home Health Testing Solutions Growth Trends by Region
- 3.2.1 Global At-Home Health Testing Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global At-Home Health Testing Solutions Market Size by Region (2021-2026)
- 3.2.3 Global At-Home Health Testing Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global At-Home Health Testing Solutions Revenue by Players
- 4.1.1 Global At-Home Health Testing Solutions Revenue by Players (2021-2026)
- 4.1.2 Global At-Home Health Testing Solutions Revenue Market Share by Players (2021-2026)
- 4.1.3 Global At-Home Health Testing Solutions Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global At-Home Health Testing Solutions Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global At-Home Health Testing Solutions Key Players Headquarters & Area Served
- 4.4 Global At-Home Health Testing Solutions Players, Product Type & Application
- 4.5 Global At-Home Health Testing Solutions Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global At-Home Health Testing Solutions Market CR5 and HHI
- 4.6.3 2025 At-Home Health Testing Solutions Tier 1, Tier 2, and Tier 3
5 At-Home Health Testing Solutions Market Size by Type
- 5.1 Global At-Home Health Testing Solutions Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global At-Home Health Testing Solutions Revenue by Type (2021-2032)
- 5.3 Global At-Home Health Testing Solutions Revenue Market Share by Type (2021-2032)
6 At-Home Health Testing Solutions Market Size by Application
- 6.1 Global At-Home Health Testing Solutions Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global At-Home Health Testing Solutions Revenue by Application (2021-2032)
- 6.3 Global At-Home Health Testing Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 New Horizon Health Limited
- 7.1.1 New Horizon Health Limited Company Information
- 7.1.2 New Horizon Health Limited Business Overview
- 7.1.3 New Horizon Health Limited At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.1.4 New Horizon Health Limited At-Home Health Testing Solutions Product Portfolio
- 7.1.5 New Horizon Health Limited Recent Developments
- 7.2 Test Onelife
- 7.2.1 Test Onelife Company Information
- 7.2.2 Test Onelife Business Overview
- 7.2.3 Test Onelife At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.2.4 Test Onelife At-Home Health Testing Solutions Product Portfolio
- 7.2.5 Test Onelife Recent Developments
- 7.3 Creative Biosciences (Guangzhou)
- 7.3.1 Creative Biosciences (Guangzhou) Company Information
- 7.3.2 Creative Biosciences (Guangzhou) Business Overview
- 7.3.3 Creative Biosciences (Guangzhou) At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.3.4 Creative Biosciences (Guangzhou) At-Home Health Testing Solutions Product Portfolio
- 7.3.5 Creative Biosciences (Guangzhou) Recent Developments
- 7.4 AnDall
- 7.4.1 AnDall Company Information
- 7.4.2 AnDall Business Overview
- 7.4.3 AnDall At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.4.4 AnDall At-Home Health Testing Solutions Product Portfolio
- 7.4.5 AnDall Recent Developments
- 7.5 Everlywell
- 7.5.1 Everlywell Company Information
- 7.5.2 Everlywell Business Overview
- 7.5.3 Everlywell At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.5.4 Everlywell At-Home Health Testing Solutions Product Portfolio
- 7.5.5 Everlywell Recent Developments
- 7.6 Modern Fertility
- 7.6.1 Modern Fertility Company Information
- 7.6.2 Modern Fertility Business Overview
- 7.6.3 Modern Fertility At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.6.4 Modern Fertility At-Home Health Testing Solutions Product Portfolio
- 7.6.5 Modern Fertility Recent Developments
- 7.7 23andMe
- 7.7.1 23andMe Company Information
- 7.7.2 23andMe Business Overview
- 7.7.3 23andMe At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.7.4 23andMe At-Home Health Testing Solutions Product Portfolio
- 7.7.5 23andMe Recent Developments
- 7.8 Cue Health
- 7.8.1 Cue Health Company Information
- 7.8.2 Cue Health Business Overview
- 7.8.3 Cue Health At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.8.4 Cue Health At-Home Health Testing Solutions Product Portfolio
- 7.8.5 Cue Health Recent Developments
- 7.9 LetsGetChecked
- 7.9.1 LetsGetChecked Company Information
- 7.9.2 LetsGetChecked Business Overview
- 7.9.3 LetsGetChecked At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.9.4 LetsGetChecked At-Home Health Testing Solutions Product Portfolio
- 7.9.5 LetsGetChecked Recent Developments
- 7.10 ixlayer
- 7.10.1 ixlayer Company Information
- 7.10.2 ixlayer Business Overview
- 7.10.3 ixlayer At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.10.4 ixlayer At-Home Health Testing Solutions Product Portfolio
- 7.10.5 ixlayer Recent Developments
- 7.11 Pixel by LabCorp
- 7.11.1 Pixel by LabCorp Company Information
- 7.11.2 Pixel by LabCorp Business Overview
- 7.11.3 Pixel by LabCorp At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.11.4 Pixel by LabCorp At-Home Health Testing Solutions Product Portfolio
- 7.11.5 Pixel by LabCorp Recent Developments
- 7.12 Thriva
- 7.12.1 Thriva Company Information
- 7.12.2 Thriva Business Overview
- 7.12.3 Thriva At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.12.4 Thriva At-Home Health Testing Solutions Product Portfolio
- 7.12.5 Thriva Recent Developments
- 7.13 MyLab Box
- 7.13.1 MyLab Box Company Information
- 7.13.2 MyLab Box Business Overview
- 7.13.3 MyLab Box At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.13.4 MyLab Box At-Home Health Testing Solutions Product Portfolio
- 7.13.5 MyLab Box Recent Developments
- 7.14 Ash
- 7.14.1 Ash Company Information
- 7.14.2 Ash Business Overview
- 7.14.3 Ash At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.14.4 Ash At-Home Health Testing Solutions Product Portfolio
- 7.14.5 Ash Recent Developments
- 7.15 Viome
- 7.15.1 Viome Company Information
- 7.15.2 Viome Business Overview
- 7.15.3 Viome At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.15.4 Viome At-Home Health Testing Solutions Product Portfolio
- 7.15.5 Viome Recent Developments
- 7.16 SiPhox Health
- 7.16.1 SiPhox Health Company Information
- 7.16.2 SiPhox Health Business Overview
- 7.16.3 SiPhox Health At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.16.4 SiPhox Health At-Home Health Testing Solutions Product Portfolio
- 7.16.5 SiPhox Health Recent Developments
- 7.17 TytoCare
- 7.17.1 TytoCare Company Information
- 7.17.2 TytoCare Business Overview
- 7.17.3 TytoCare At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.17.4 TytoCare At-Home Health Testing Solutions Product Portfolio
- 7.17.5 TytoCare Recent Developments
- 7.18 Randox Health
- 7.18.1 Randox Health Company Information
- 7.18.2 Randox Health Business Overview
- 7.18.3 Randox Health At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.18.4 Randox Health At-Home Health Testing Solutions Product Portfolio
- 7.18.5 Randox Health Recent Developments
- 7.19 Nurx
- 7.19.1 Nurx Company Information
- 7.19.2 Nurx Business Overview
- 7.19.3 Nurx At-Home Health Testing Solutions Revenue and Gross Margin (2021-2026)
- 7.19.4 Nurx At-Home Health Testing Solutions Product Portfolio
- 7.19.5 Nurx Recent Developments
8 North America
- 8.1 North America At-Home Health Testing Solutions Revenue (2021-2032)
- 8.2 North America At-Home Health Testing Solutions Revenue by Type (2021-2032)
- 8.2.1 North America At-Home Health Testing Solutions Revenue by Type (2021-2026)
- 8.2.2 North America At-Home Health Testing Solutions Revenue by Type (2027-2032)
- 8.3 North America At-Home Health Testing Solutions Revenue Share by Type (2021-2032)
- 8.4 North America At-Home Health Testing Solutions Revenue by Application (2021-2032)
- 8.4.1 North America At-Home Health Testing Solutions Revenue by Application (2021-2026)
- 8.4.2 North America At-Home Health Testing Solutions Revenue by Application (2027-2032)
- 8.5 North America At-Home Health Testing Solutions Revenue Share by Application (2021-2032)
- 8.6 North America At-Home Health Testing Solutions Revenue by Country
- 8.6.1 North America At-Home Health Testing Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America At-Home Health Testing Solutions Revenue by Country (2021-2026)
- 8.6.3 North America At-Home Health Testing Solutions Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe At-Home Health Testing Solutions Revenue (2021-2032)
- 9.2 Europe At-Home Health Testing Solutions Revenue by Type (2021-2032)
- 9.2.1 Europe At-Home Health Testing Solutions Revenue by Type (2021-2026)
- 9.2.2 Europe At-Home Health Testing Solutions Revenue by Type (2027-2032)
- 9.3 Europe At-Home Health Testing Solutions Revenue Share by Type (2021-2032)
- 9.4 Europe At-Home Health Testing Solutions Revenue by Application (2021-2032)
- 9.4.1 Europe At-Home Health Testing Solutions Revenue by Application (2021-2026)
- 9.4.2 Europe At-Home Health Testing Solutions Revenue by Application (2027-2032)
- 9.5 Europe At-Home Health Testing Solutions Revenue Share by Application (2021-2032)
- 9.6 Europe At-Home Health Testing Solutions Revenue by Country
- 9.6.1 Europe At-Home Health Testing Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe At-Home Health Testing Solutions Revenue by Country (2021-2026)
- 9.6.3 Europe At-Home Health Testing Solutions Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China At-Home Health Testing Solutions Revenue (2021-2032)
- 10.2 China At-Home Health Testing Solutions Revenue by Type (2021-2032)
- 10.2.1 China At-Home Health Testing Solutions Revenue by Type (2021-2026)
- 10.2.2 China At-Home Health Testing Solutions Revenue by Type (2027-2032)
- 10.3 China At-Home Health Testing Solutions Revenue Share by Type (2021-2032)
- 10.4 China At-Home Health Testing Solutions Revenue by Application (2021-2032)
- 10.4.1 China At-Home Health Testing Solutions Revenue by Application (2021-2026)
- 10.4.2 China At-Home Health Testing Solutions Revenue by Application (2027-2032)
- 10.5 China At-Home Health Testing Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia At-Home Health Testing Solutions Revenue (2021-2032)
- 11.2 Asia At-Home Health Testing Solutions Revenue by Type (2021-2032)
- 11.2.1 Asia At-Home Health Testing Solutions Revenue by Type (2021-2026)
- 11.2.2 Asia At-Home Health Testing Solutions Revenue by Type (2027-2032)
- 11.3 Asia At-Home Health Testing Solutions Revenue Share by Type (2021-2032)
- 11.4 Asia At-Home Health Testing Solutions Revenue by Application (2021-2032)
- 11.4.1 Asia At-Home Health Testing Solutions Revenue by Application (2021-2026)
- 11.4.2 Asia At-Home Health Testing Solutions Revenue by Application (2027-2032)
- 11.5 Asia At-Home Health Testing Solutions Revenue Share by Application (2021-2032)
- 11.6 Asia At-Home Health Testing Solutions Revenue by Country
- 11.6.1 Asia At-Home Health Testing Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia At-Home Health Testing Solutions Revenue by Country (2021-2026)
- 11.6.3 Asia At-Home Health Testing Solutions Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA At-Home Health Testing Solutions Revenue (2021-2032)
- 12.2 SAMEA At-Home Health Testing Solutions Revenue by Type (2021-2032)
- 12.2.1 SAMEA At-Home Health Testing Solutions Revenue by Type (2021-2026)
- 12.2.2 SAMEA At-Home Health Testing Solutions Revenue by Type (2027-2032)
- 12.3 SAMEA At-Home Health Testing Solutions Revenue Share by Type (2021-2032)
- 12.4 SAMEA At-Home Health Testing Solutions Revenue by Application (2021-2032)
- 12.4.1 SAMEA At-Home Health Testing Solutions Revenue by Application (2021-2026)
- 12.4.2 SAMEA At-Home Health Testing Solutions Revenue by Application (2027-2032)
- 12.5 SAMEA At-Home Health Testing Solutions Revenue Share by Application (2021-2032)
- 12.6 SAMEA At-Home Health Testing Solutions Revenue by Country
- 12.6.1 SAMEA At-Home Health Testing Solutions Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA At-Home Health Testing Solutions Revenue by Country (2021-2026)
- 12.6.3 SAMEA At-Home Health Testing Solutions Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst